Lexicon Pharmaceuticals, Inc. (LXRX) stock
LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)
Close on Nov 17, 2026Market cap $792.02MP/E –Yield –
Lexicon Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lexicon Pharmaceuticals's enterprise value was $696.48M on Nov 11, 2026, against $434.62M a year earlier. Over the last 5 years it ranged from $29.62M to $900.73M, with a median of $283.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $696.48M | +109.7% |
| 2025 | Dec 31, 2025 | $332.21M | +490.8% |
| 2024 | Dec 31, 2024 | $56.23M | -71.5% |
| 2023 | Dec 29, 2023 | $197.43M | +6.8% |
| 2022 | Dec 30, 2022 | $184.87M | -58.0% |
| 2021 | Dec 31, 2021 | $440.01M | +55.5% |
| 2020 | Dec 31, 2020 | $282.88M | -29.3% |
| 2019 | Dec 31, 2019 | $400.02M | -47.4% |
| 2018 | Dec 31, 2018 | $759.80M | -19.1% |
| 2017 | Dec 29, 2017 | $939.23M | -20.6% |
| 2016 | Dec 30, 2016 | $1.18B | +1.5% |
| 2015 | Dec 31, 2015 | $1.17B | +170.7% |
| 2014 | Dec 31, 2014 | $430.68M | -45.6% |
| 2013 | Dec 31, 2013 | $792.02M | -2.5% |
| 2012 | Dec 31, 2012 | $812.07M | – |
See a number that looks wrong?